K
Keen Vision Acquisition Corp.
Period
FY 2025
Revenue
—
Net Income
$1.91M
Total Assets
$57.04M
Equity
$-7.01M
Shares Out
5.51M
Op. Cash Flow
$-784.1K
Business
Keen Vision Acquisition Corp. is a blank-check company formed to identify and complete a merger or similar business combination with a growth-focused company. The company targets businesses in biotechnology, consumer goods, or agriculture, evaluated based on ESG imperatives. As of February 2026, it has entered a binding letter of intent with Novoheart Group Limited, engaged in pre-clinical human disease modeling and drug discovery.
Summary from 10-K filed 2026-03-25
Financials
Consolidated Statement of Income
Year Ended · In millions, except per-share amounts
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 |
|---|---|---|---|---|---|
| Formation and operating costs | −743,509 | −1 | −478,676 | 697 | |
| Dividend income earned in investments held in Trust Account | 3 | 7 | 2 | — | |
| Interest income earned in investments held in Trust Account | — | 2 | 2 | 4 | |
| Interest income | 1 | 26 | 37 | — | |
| Total other income | 3 | 9 | 2 | 4 | |
| NET INCOME | 2 | 7 | 1 | −693 | |
| Transfer to realized gain in investments held in Trust Account | — | −2 | — | — | |
| COMPREHENSIVE INCOME | 2 | 6 | 3 | −693 |
Consolidated Balance Sheet
As of · In millions, except per-share amounts
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 | FY 2021 2021-12-31 |
|---|---|---|---|---|---|---|
| Cash at bank | 11,206 | 54,548 | 631,753 | — | — | |
| Prepayment | 25,550 | 9,238 | 233,862 | 2,598 | — | |
| Total current assets | 36,756 | 63,786 | 865,615 | 80,307 | — | |
| Cash and investments held in trust account | 57 | 70 | 155 | — | — | |
| TOTAL ASSETS | 57 | 70 | 156 | 194,807 | — | |
| Accrued expenses | 73,496 | 97,813 | 4,000 | — | — | |
| Extension promissory note payable | 3 | 600,000 | — | — | — | |
| Total current liabilities | 4 | 1 | 14,000 | 173,573 | — | |
| Deferred underwriting compensation | 3 | 3 | 3 | — | — | |
| TOTAL LIABILITIES | 7 | 4 | 3 | 173,573 | — | |
| Commitments and contingencies (Note 7) | — | — | — | — | — | |
| Ordinary shares, 4,822,346 and 14,950,000 shares subject to possible redemption issued and outstanding as of December 31, 2025 and 2024, respectively | 57 | 70 | 155 | — | — | |
| Ordinary shares, $0.0001 par value; 500,000,000 shares authorized; 4,416,075 shares issued and outstanding as of December 31, 2025 and 2024 (excluding 4,822,346 and 14,950,000 shares subject to possible redemption, respectively) | 442 | 442 | 442 | 374 | — | |
| Accumulated deficit | −7 | −4 | −4 | −3,766 | — | |
| Total Shareholders Deficit | −7 | −4 | −2 | 21,234 | 21,927 | |
| TOTAL LIABILITIES AND SHAREHOLDERS DEFICIT | 57 | 70 | 156 | 194,807 | — |
Consolidated Statement of Cash Flows
Year Ended · In millions, except per-share amounts
| Concept | Trend | FY 2025 2025-12-31 | FY 2024 2024-12-31 | FY 2023 2023-12-31 | FY 2022 2022-12-31 |
|---|---|---|---|---|---|
| Prepayment | −16,312 | 224,624 | −231,264 | −2,598 | |
| Accrued expenses | −24,317 | 93,813 | 4,000 | — | |
| Net cash used in operating activities | −784,137 | −1 | −705,903 | −3,291 | |
| Cash withdrawn from Trust Account in connection to redemption | 18 | 92 | — | — | |
| Extension payments deposited in Trust Account | −2 | −600,000 | — | — | |
| Net cash provided by investing activities | 16 | 92 | −151 | — | |
| Advance from a related party | 740,795 | 565,085 | 318,427 | 56,076 | |
| Proceed from extension promissory note - related party | 2 | 600,000 | — | — | |
| Redemption of common stock | −18 | −92 | — | — | |
| Net cash used in financing activities | −15 | −91 | 153 | 56,076 | |
| NET CHANGE IN CASH | −43,342 | −577,205 | 554,044 | 52,785 | |
| Accretion of carrying value to redemption value | 5 | 8 | 3 | — |
Filings
Filing historySign up free to browse every 10-K, 10-Q, 8-K, and proxy this filer has submitted to the SEC.Sign up free · Upgrade to Pro
Material Events
Material EventsTrack every 8-K filing and material event — AI-summarized, timelined, and alertable.Sign up free · Upgrade to Pro
Insiders
Insider ActivitySee executive buy/sell windows and insider trade activity over rolling 30/90/365-day windows.Sign up free · Upgrade to Pro
Institutional Holders
Institutional HoldersSee which funds hold this stock and track position changes quarter over quarter.Sign up free · Upgrade to Pro
Frequently asked questions
What is Keen Vision Acquisition Corp.'s CIK number?
Keen Vision Acquisition Corp.'s SEC CIK number is 0001889983 (1889983). The CIK (Central Index Key) is the permanent identifier the SEC assigns to every EDGAR filer — unlike a ticker symbol, it never changes.
Where can I find Keen Vision Acquisition Corp.'s SEC filings?
All of Keen Vision Acquisition Corp.'s EDGAR filings — 10-K annual reports, 10-Q quarterly reports, 8-K material events, and insider transactions — are listed on this page, sourced live from SEC EDGAR.